The Interventional Cardiology Market: Poised for Significant Growth
Explore the promising future of the Interventional Cardiology market, driven by technological advancements and key players’ investment in research.
Read MoreExplore the promising future of the Interventional Cardiology market, driven by technological advancements and key players’ investment in research.
Read MoreArtificial intelligence (AI) is reshaping the field of robotic pathology, addressing patient concerns and enhancing satisfaction. By providing comprehensive information, personalizing the patient experience, improving procedural accuracy, and optimizing post-procedure care
Read MoreThis article delves into the transformative role of Agatston scores in predicting coronary heart disease. Leveraging cutting-edge medical technology, researchers are recalibrating the approach to risk categorization, offering a new dawn in cardiovascular health management.
Read MoreA retrospective study of U.S. veterans with newly diagnosed head and neck squamous cell carcinoma revealed suboptimal control of cardiovascular risk factors, leading to increased risk of stroke, myocardial infarction, and mortality. Black race was associated with a higher risk of uncontrolled risk factors. The findings underscore the need for targeted interventions to mitigate cardiac risk in this population.
Read MoreThe recently conducted POST-PCI trial examined the effectiveness of routine functional testing after percutaneous coronary intervention (PCI). The trial findings indicate that routine stress testing in the absence of symptoms does not prevent adverse cardiovascular events or provide additional value beyond standard care.
Read More